Form 4: Agilon Health CEO Steven Sell Reports Stock Transactions Following PSU Vesting
SEC Form 4 Filing
Agilon Health's CEO, Steven Sell, reports the vesting and settlement of performance-based restricted stock units (PSUs) and related tax withholding.
Summary
- On March 14, 2025, Agilon Health CEO Steven Sell vested 42,426 shares of common stock related to performance-based restricted stock units (PSUs).
- These PSUs were granted on April 14, 2022, and vested based on the company's revenue and adjusted EBITDA performance from January 1, 2022, through December 31, 2024, achieving 87% of the predetermined goals.
- The company withheld 15,563 shares to cover income tax obligations related to the PSU settlement at a price of $4.05.
- Following these transactions, Sell directly owns 355,310 shares and indirectly owns 67,590 shares through a trust.
- The report also indicates that Sell's holdings include restricted stock units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The vesting of PSUs suggests the company met a significant portion of its performance goals. The filing itself is a routine disclosure.
Positives
- The vesting of PSUs indicates that Agilon Health achieved a significant portion (87%) of its predetermined revenue and adjusted EBITDA goals over the performance period.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the alignment of executive incentives with company performance.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity awards like PSUs to incentivize executives to achieve specific financial goals.
- The vesting of PSUs based on revenue and adjusted EBITDA is a common practice, aligning executive compensation with key performance indicators.
- Tax withholding upon vesting of equity awards is a standard procedure in executive compensation.
Stakeholder Impact
- The vesting of PSUs aligns executive compensation with company performance, potentially benefiting shareholders.
- The disclosure provides transparency to shareholders regarding executive stock ownership.
Key Dates
| Date | Description |
|---|---|
| 04/14/2022 | Date the performance-based restricted stock units (PSUs) were granted. |
| 01/01/2022 | Start date of the three-year performance period for the PSUs. |
| 12/31/2024 | End date of the three-year performance period for the PSUs. |
| 03/14/2025 | Date of the transaction (vesting of PSUs and tax withholding). |
| 03/18/2025 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.